The use of bladder antimuscarinics is very common in the elderly. However, recent
population-based studies that assessed the use of anticholinergics or bladder …

Aim: To determine the economic burden associated with anticholinergic medication use in
adults with overactive bladder (OAB) in the USA. Methods: A systematic literature review …

OBJECTIVE: To develop and externally validate a prediction model for anticholinergic
response in patients with overactive bladder (OAB). METHODS: A machine learning model …

Objective To report out-of-pocket costs associated with overactive bladder (OAB)
medications among Medicare beneficiaries and the uninsured. Methods We performed a …

Background Overactive bladder (OAB) is associated with considerable clinical and
economic burden. Treatment of patients with OAB using anticholinergics is limited by …

Introduction Vibegron is a β3-adrenergic receptor agonist approved for overactive bladder
(OAB). This analysis assessed real-world adherence and persistence with vibegron in …

Objective To assess the relative prevalence and factors affecting the prescription of
medication combinations with a theoretical efficacy limiting pharmacodynamic interaction …

目的: 为我国医保预算影响分析(BIA) 研究的开展提供经验借鉴. 方法: 在PubMed, ProQuest,
中国知网, 万方和中国生物医学文献服务系统等数据库中检索建库至今的中美两国关于医保BIA …

BACKGROUND: Traditional budget impact models predict the financial consequences of a
new drug entering the market. This study provides an example of applying the budget impact …

Overactive bladder (OAB) is a heterogeneous syndrome estimated to affect approximately
10% to 15% of men and women globally. OAB not only negatively impacts quality of life but …